Dextrose Monohydrate 5% Injection
Fresenius Kabi USA, LLC · Limited Availability · Reason: Demand increase for the drug
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 02/14/2022
- Package NDC
- 65219-458-30
- Generic name
- Dextrose Monohydrate 5% Injection
- Contact info
- 888-386-1300
- Availability
- Limited Availability
- Related info
- Check wholesalers for inventory
- Update date
- 11/03/2026
- Dosage form
- Injection
- Presentation
- Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-458-30)
- Company name
- Fresenius Kabi USA, LLC
- Shortage reason
- Demand increase for the drug
- Status
- Current
- Therapeutic category
- Endocrinology/Metabolism, Gastroenterology, Other, Pediatric
- Harmonized identifiers (openFDA)
- Application number
- ANDA207449
- Brand name
- DEXTROSE
- Generic name
- DEXTROSE MONOHYDRATE
- Manufacturer name
- FRESENIUS KABI USA, LLC
- Product NDC
- 65219-458, 65219-456, 65219-464, 65219-460, 65219-462
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- DEXTROSE MONOHYDRATE
- RxCUI
- 1795607, 1795609, 1795610, 1795612, 1795616
- SPL ID
- efc3b0c9-518a-47db-bb3e-ebdfd4646e9b
- SPL set ID
- 576a22d8-5f2f-497e-80ad-1842ca74bb53
- Package NDC
- 65219-456-05, 65219-456-60, 65219-464-05, 65219-464-50, 65219-458-05, 65219-458-30, 65219-460-05, 65219-460-20, 65219-462-05, 65219-462-10
- UNII
- LX22YL083G